Sanyin Formula Enhances the Therapeutic Efficacy of Paclitaxel in Triple-Negative Breast Cancer Metastases through the JAK/STAT3 Pathway in Mice

• Hauptverfasser: Chunyu Wu (Verfasst von), Chenping Sun (Verfasst von), Xianghui Han (Verfasst von), Yiyi Ye (Verfasst von), Yuenong Qin (Verfasst von), Sheng Liu (Verfasst von)
• Format: Buch
• Veröffentlicht: MDPI AG, 2022-12-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Sanyin formula (SYF) is used as a complementary treatment for triple-negative breast cancer (TNBC). The purpose of this study was to identify the potential functional components and clarify the underlying molecular mechanisms of SYF in TNBC. High-performance liquid chromatography-tandem mass spectro...